TradingKey

关于 Pulmonx Corp 公司

Pulmonx Corporation 是一家商业阶段的医疗技术公司。该公司为患有严重肺气肿（一种慢性阻塞性肺病）的患者提供微创治疗。其解决方案由 Zephyr 支气管内瓣膜（Zephyr 瓣膜）、Chartis 肺部评估系统（Chartis 系统）和 StratX 肺分析平台（StratX 平台）组成，旨在治疗严重肺气肿患者。StratX 平台是一种基于云的定量 CT 分析服务，可为医生提供针对其解决方案设计的报告，其中包括有关肺气肿破坏、裂隙完整性和肺叶体积的信息，以帮助确定使用 Zephyr 瓣膜治疗的目标肺叶。Chartis 系统是一种球囊导管和控制台系统，带有流量和压力传感器，旨在评估侧支通气的存在，并已在多项随机对照临床试验中得到验证。

公司简介

公司代码LUNG

公司名称Pulmonx Corp

上市日期Oct 01, 2020

CEOMr. Steven S. (Steve) Williamson

员工数量291

证券类型Ordinary Share

年结日Oct 01

公司地址700 Chesapeake Dr

城市REDWOOD CITY

上市交易所NASDAQ Global Select Consolidated

国家United States of America

邮编94063

电话16509342600

网址https://pulmonx.com/

公司代码LUNG

上市日期Oct 01, 2020

CEOMr. Steven S. (Steve) Williamson

公司高管

名称

名称/职务

职务

持股

持股变动

Mr. Geoffrey Beran Rose

Chief Commercial Officer

237.06K

-2.85%

Mr. Daniel P. (Dan) Florin

Independent Director

102.02K

+145.58%

Mr. Richard M. (Rich) Ferrari

Independent Director

71.81K

+68.35%

Ms. Tiffany Sullivan

Independent Director

59.98K

+162.74%

Mr. Thomas William Burns

Independent Director

58.18K

+176.67%

Mr. Steven S. (Steve) Williamson

President, Chief Executive Officer, Director

30.45K

-24.58%

Mr. Mehul Joshi

Chief Financial Officer

11.52K

-41.16%

Mr. Brian Johnston

Investor Relations

--

Mr. David A. Lehman

General Counsel

--

Ms. Georgia Garinoismelenikiotou

Independent Director

--

名称

名称/职务

职务

持股

持股变动

Mr. Geoffrey Beran Rose

Chief Commercial Officer

237.06K

-2.85%

Mr. Daniel P. (Dan) Florin

Independent Director

102.02K

+145.58%

Mr. Richard M. (Rich) Ferrari

Independent Director

71.81K

+68.35%

Ms. Tiffany Sullivan

Independent Director

59.98K

+162.74%

Mr. Thomas William Burns

Independent Director

58.18K

+176.67%

Mr. Steven S. (Steve) Williamson

President, Chief Executive Officer, Director

30.45K

-24.58%

收入明细

单位: USD更新时间: 7月6日周日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

暂无数据

地区USD

名称

营收

占比

United States

14.22M

63.10%

Europe, Middle-East and Africa ("EMEA")

5.48M

24.33%

Asia Pacific

2.79M

12.40%

Other International

38.00K

0.17%

业务

地区

暂无数据

股东统计

更新时间: 7月2日周三

持股股东

股东类型

持股股东

占比

PRIMECAP Management Company

13.45%

Fidelity Management & Research Company LLC

11.71%

Morgan Stanley & Co. LLC

7.27%

BlackRock Institutional Trust Company, N.A.

6.30%

The Vanguard Group, Inc.

5.67%

Other

55.60%

持股股东

占比

PRIMECAP Management Company

13.45%

Fidelity Management & Research Company LLC

11.71%

Morgan Stanley & Co. LLC

7.27%

BlackRock Institutional Trust Company, N.A.

6.30%

The Vanguard Group, Inc.

5.67%

Other

55.60%

股东类型

持股股东

占比

Investment Advisor

51.20%

Hedge Fund

16.03%

Investment Advisor/Hedge Fund

14.74%

Research Firm

9.33%

Individual Investor

4.21%

Sovereign Wealth Fund

0.38%

Bank and Trust

0.19%

Pension Fund

0.05%

Insurance Company

0.03%

Other

3.85%

机构持股

更新时间: 7月1日周二

报告期

机构数

持股数

持股占比

持股变动

2025Q2

286

39.72M

98.66%

-2.86M

2025Q1

296

39.33M

97.70%

-4.34M

2024Q4

300

39.10M

98.27%

-6.73M

2024Q3

306

39.39M

100.59%

-8.60M

2024Q2

305

38.59M

99.39%

-11.14M

2024Q1

300

38.64M

99.54%

-10.45M

2023Q4

294

37.11M

96.84%

-10.90M

2023Q3

296

35.84M

94.15%

-16.29M

2023Q2

300

36.45M

96.58%

-16.49M

2023Q1

313

37.10M

98.35%

-13.03M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

PRIMECAP Management Company

5.41M

13.45%

-97.53K

-1.77%

Mar 31, 2025

Fidelity Management & Research Company LLC

4.71M

11.71%

-443.86K

-8.61%

Mar 31, 2025

Morgan Stanley & Co. LLC

2.93M

7.27%

+396.76K

+15.68%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

2.54M

6.3%

-38.08K

-1.48%

Mar 31, 2025

The Vanguard Group, Inc.

2.28M

5.67%

-1.15K

-0.05%

Mar 31, 2025

Deerfield Management Company, L.P.

1.89M

4.69%

+355.24K

+23.15%

Mar 31, 2025

BNP Paribas Asset Management USA, Inc.

1.25M

3.11%

--

Mar 31, 2025

DWS Investments UK Limited

1.13M

2.81%

+31.06K

+2.82%

Mar 31, 2025

Silvercrest Asset Management Group LLC

930.56K

2.31%

+930.56K

--

Mar 31, 2025

Geode Capital Management, L.L.C.

927.54K

2.3%

+25.30K

+2.80%

Mar 31, 2025

持股ETF

更新时间: 8月2日周六

机构名称

占比

iShares Micro-Cap ETF

0.02%

iShares Russell 2000 Growth ETF

0.01%

Proshares Ultra Russell 2000

0%

Avantis US Equity ETF

0%

iShares Core S&P Total U.S. Stock Market ETF

0%

Global X Russell 2000 ETF

0%

Schwab U.S. Broad Market ETF

0%

FlexShares Morningstar US Market Factor Tilt Index Fund

0%

Goldman Sachs Innovate Equity ETF

0%

SPDR S&P Health Care Equipment ETF

0%

iShares Micro-Cap ETF

占比0.02%

iShares Russell 2000 Growth ETF

占比0.01%

Proshares Ultra Russell 2000

占比0%

Avantis US Equity ETF

占比0%

iShares Core S&P Total U.S. Stock Market ETF

占比0%

Global X Russell 2000 ETF

占比0%

Schwab U.S. Broad Market ETF

占比0%

FlexShares Morningstar US Market Factor Tilt Index Fund

占比0%

Goldman Sachs Innovate Equity ETF

占比0%

SPDR S&P Health Care Equipment ETF

占比0%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

Pulmonx Corp

1.695USD

Pulmonx Corp

1.695

概览

公司

财务